Literature DB >> 24138457

Treatment of pediatric pyogenic granulomas using β-adrenergic receptor antagonists.

Lara Wine Lee1, Kiera L Goff, Joseph M Lam, David W Low, Albert C Yan, Leslie Castelo-Soccio.   

Abstract

Propranolol and timolol are nonselective ß-adrenergic antagonists that induce peripheral vasoconstriction and affect angiogenic cytokines. Oral and topical ß-blocker therapy has become the de facto first-line treatment for complicated infantile hemangiomas because of its superior efficacy and tolerability. Pyogenic granulomas or lobular capillary hemangiomas are common acquired vascular tumors accounting for 0.5% of all skin nodules in children. Although they are benign vascular proliferations, treatment is often sought because of recurrent episodes of bleeding and for cosmetic considerations. Numerous treatment options are available, but recurrence rates are high. Noninvasive methods of treatment are being sought, particularly for young children. Herein we report a series of seven cases of cutaneous and mucosal pyogenic granulomas treated successfully using oral or topical ß-blockers.
© 2013 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24138457     DOI: 10.1111/pde.12217

Source DB:  PubMed          Journal:  Pediatr Dermatol        ISSN: 0736-8046            Impact factor:   1.588


  10 in total

1.  Are topical beta-blockers really effective "in real life" for targeted therapy-induced paronychia.

Authors:  Vincent Sibaud; Eline Casassa; Mirella D'Andrea
Journal:  Support Care Cancer       Date:  2019-03-07       Impact factor: 3.603

2.  23-Year-old male with multiple giant facial pyogenic granulomas being treated with combined topical timolol and steroid: A case report.

Authors:  Kheder Kheder; Hala Khaddam; Hala Almohi Alsaid Mushaweh; Rasha Nabhan
Journal:  Ann Med Surg (Lond)       Date:  2022-09-01

3.  Topical treatment of pyogenic granulomas in a pediatric population: A single-institution retrospective review.

Authors:  Kelly K Barry; Marilyn G Liang; Elena B Hawryluk
Journal:  JAAD Int       Date:  2022-05-07

4.  Somatic Activating RAS Mutations Cause Vascular Tumors Including Pyogenic Granuloma.

Authors:  Young H Lim; Stephanie R Douglas; Christine J Ko; Richard J Antaya; Jennifer M McNiff; Jing Zhou; Keith A Choate; Deepak Narayan
Journal:  J Invest Dermatol       Date:  2015-02-19       Impact factor: 8.551

5.  Vulvar Lobular Capillary Hemangioma: A Rare Location for a Frequent Entity.

Authors:  F Abreu-Dos-Santos; S Câmara; F Reis; T Freitas; H Gaspar; M Cordeiro
Journal:  Case Rep Obstet Gynecol       Date:  2016-12-29

6.  Pyogenic Granuloma - A Common Benign Vascular Tumor with Variable Clinical Presentation: New Findings and Treatment Options.

Authors:  Uwe Wollina; Dana Langner; Katlein França; Serena Gianfaldoni; Torello Lotti; Georgi Tchernev
Journal:  Open Access Maced J Med Sci       Date:  2017-07-13

Review 7.  Genetic investigation of childhood vascular tumor biology reveals pathways for therapeutic intervention.

Authors:  Shayan Cheraghlou; Young Lim; Keith Choate
Journal:  F1000Res       Date:  2019-04-30

Review 8.  Efficacy of topical beta-blockers in the management of EGFR-inhibitor induced paronychia and pyogenic granuloma-like lesions: case series and review of the literature.

Authors:  Pietro Sollena; Maria Mannino; Francesco Tassone; Maria Alessandra Calegari; Ettore D'Argento; Ketty Peris
Journal:  Drugs Context       Date:  2019-11-06

9.  Treatment of Chemotherapy-Induced Subungual Pyogenic Granuloma with Topical Timolol Solution.

Authors:  Natalie M Williams; Brian W Morrison
Journal:  Skin Appendage Disord       Date:  2020-11-10

10.  Topical timolol for the treatment of conjunctival pyogenic granulomas: Outcomes and effect on intraocular pressure.

Authors:  Akshay Gopinathan Nair; Ronnie Jacob George; Sundaram Natarajan; Vandana Jain
Journal:  Indian J Ophthalmol       Date:  2020-10       Impact factor: 1.848

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.